Empowering Healthcare Professionals: Key to Effective Pharmacovigilance and Adverse Drug Reaction - Reporting in India

Abstract

Adverse drug reaction (ADR) reporting is a crucial component of a Pharmacovigilance (PV) system as it helps ensure patient safety and allows for continuous surveillance of pharmaceutical products. However, in India, there is a significant challenge in ADR reporting by healthcare professionals (HCPs). Indisputably, the HCPs are now playing a much wider role in enhancing healthcare. However, under reporting of ADRscontinues to be a problem that poses a significant threat to patient safety and weakens the effectiveness of the national pharmacovigilance program. This ultimately impacts the overall quality of the healthcare system. This article aims to emphasize the importance of ADR reporting and the challenges faced by the HCPs in India. It also discusses the process of reporting ADR in the country and concludes by proposing potential solutions to increase ADR reporting and to strengthen India’s pharmacovigilance framework.